Merck & Company Inc (MRK)

71.42
-0.18(-0.25%)
  • Volume:
    548
  • Bid/Ask:
    71.33/71.42
  • Day's Range:
    70.82 - 71.42
  • Type:Equity
  • Market:Germany
  • ISIN:US58933Y1055
  • WKN:A0YD8Q

MRK Overview

Prev. Close
71.6
Day's Range
70.82-71.42
Revenue
-
Open
70.94
52 wk Range
59.25-79.5
EPS
-
Volume
548
Market Cap
178.11B
Dividend (Yield)
2.76
(3.76%)
Average Vol. (3m)
1,689
P/E Ratio
32.64
Beta
-
1-Year Change
4.07%
Shares Outstanding
2,525,943,936
Next Earnings Date
Feb 03, 2022
What is your sentiment on Merck & Company Inc?
or
Market is currently closed. Voting is open during market hours.

Merck & Company Inc Company Profile

Employees
73500

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyStrong Buy
Technical IndicatorsBuyBuyBuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • It’s been moving up slowly but surely, that’s good enough given the current market situation
    0
    • Buffett is a long investor of MRK.
      0
      • is it worth to entry now in Merck ?
        0
        • merck got treatment approved with great fundamentals and undervalued pricing below 100 per share. id say now's around the time to buy before the rallies.
          0
          • today 12/27 is working New York Exchange and European Exchanges do you know that please ?
            0
        • has been quit here lol the buyers bought air. told u. chart = defensive = channel. = simple, basic investing knowledge
          1
          • this price is a God gift. Buy 100 share now. 72.62
            0
            • dropping ?
              1
              • MRk is oversold. Support of 72$ should hold imo.
                0
              • i bought mrk, i'm watching when to entry
                0
            • Bought 240 shares today for 72,30$ long
              0
              • I think this is a good time to pick up some more of this! It can only get better!
                0
                • Buy! Buy! Buy! This is only going up!
                  0
                  • aah a drop to the second line is a second buy place then just under 72$
                    0
                    • want technical? almost its 72.85$ i think majority of wallstreet (also me) buying this level tp? thats 79.7$ , did bought 10pieces now already
                      1
                      • think well, get well.I hope today will be a good day.
                        0
                        • i see desperate people this isnt moderna yea your reasons to buy would for sure push this up few % if it was a nasdaq stock its not + its defensive then its chart trade
                          0
                          • Cambodia purchases 4 million Molnupiravir tablets. these numbers are getting large
                            0
                            • thats a weird headline of the cambodian news especially cause merck always press release when a country large ammount of its product idk if its true tho, it dont make much sense tbh for cambodia to buy now 4M pill
                              0
                          • Merk covid pill becomes Christmas gift to UK peoples
                            0
                            • Merck's Keytruda approved as adjuvant therapy for stage IIb, IIc melanoma source => seeking alpha
                              0
                              • Merck & Co. Inc. said Friday that it has entered into an agreement to supply the Government of Canada with up to one million patient courses of its COVID-19 pill, molnupiravir, which is being developed in collaboration with Ridgeback Biotherapeutics.
                                0
                                • Heading to GREEN land. 🚀🚀🚀🚀🚀🚀🚀
                                  1
                                  • how more u call bullish how more down it goes
                                    0
                                    • The US Food and Drug Administration has accepted a Priority Review of the pneumococcal 15-valent conjugate vaccine VAXNEUVANCE™ in children aged 17 years and younger. Merck has a lot of different stuff they are bringing to market
                                      0
                                      • 🚀🚀🚀🚀🚀🚀🚀
                                        0
                                        • still in red ofcourse but now u have to buy it tp 76$ friday/monday it gets hit. without a headline
                                          1
                                          • Biden administration aims to obtain 13M COVID antiviral pills, equitable distributionThere are so many reasons to buy this stock, I'm glad I did.
                                            0
                                            • The federal government has agreed to buy 3.1M courses of Merck's antiviral molnupiravir worth ~$2.2B. The government has also agreed to purchase 10M doses of Pfizer's (PFE -2.0%) Paxlovid
                                              0
                                          • The German health minister Jens Spahn has just signed the contract with Merck & Co. Inc. about the first shipment of anti-covid-drug Lagevrio. The first shipment will be delivered in December 2021. Source: Handelsblatt
                                            0
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.